| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.34B | 56.48B | 46.68B | 39.34B | 35.31B | 39.09B |
| Gross Profit | 21.34B | 21.86B | 19.84B | 14.89B | 16.65B | 17.07B |
| EBITDA | 4.35B | 4.81B | 4.61B | 2.32B | 2.19B | 3.00B |
| Net Income | 2.60B | 2.63B | 2.54B | 780.95M | 1.01B | 1.43B |
Balance Sheet | ||||||
| Total Assets | 106.23B | 92.04B | 92.13B | 69.28B | 64.18B | 61.66B |
| Cash, Cash Equivalents and Short-Term Investments | 52.63B | 19.75B | 47.52B | 12.49B | 14.08B | 17.34B |
| Total Debt | 45.34B | 42.57B | 42.64B | 33.65B | 31.55B | 29.95B |
| Total Liabilities | 87.44B | 73.18B | 75.38B | 54.42B | 49.41B | 47.87B |
| Stockholders Equity | 17.80B | 17.87B | 16.15B | 14.31B | 14.10B | 13.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.19B | 729.47M | -853.52M | -4.75B | 6.63B |
| Operating Cash Flow | 0.00 | -3.94B | 817.00M | -474.00M | -4.61B | 6.85B |
| Investing Cash Flow | 0.00 | -402.61M | -771.45M | 51.88M | -950.44M | -1.44B |
| Financing Cash Flow | 0.00 | -20.83M | 10.78B | -631.79M | 2.48B | -5.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.11B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
76 Outperform | ¥21.24B | 3.91 | ― | 5.27% | 18.05% | 34.17% | |
75 Outperform | ¥41.40B | 7.03 | 6.18% | 4.42% | 1.56% | -9.90% | |
72 Outperform | $2.04T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥27.58B | 43.28 | ― | 18.63% | 21.38% | ― | |
60 Neutral | ¥123.81B | 8.60 | 5.11% | 5.07% | -19.64% | -31.08% |